GALECTIN THERAPEUTICS INC. Warrants and Rights Outstanding
GALECTIN THERAPEUTICS INC. (GALT) had Warrants and Rights Outstanding of $500.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2022-11-14
- 2022-09-30: Warrants and Rights Outstanding $500.00K.
- 2021-12-31: Warrants and Rights Outstanding $500.00K.
- 2021-09-30: Warrants and Rights Outstanding $696.00K.
- 2015-11-25: Warrants and Rights Outstanding $5.89M.
| Period end | Warrants and Rights Outstanding |
|---|---|
| 2022-09-30 | $500.00K 10-Q · filed 2022-11-14 |
| 2021-12-31 | $500.00K 10-K · filed 2022-03-31 |
| 2021-09-30 | $696.00K 10-Q · filed 2021-11-15 |
| 2015-11-25 | $5.89M 10-K · filed 2017-03-28 |
| 2010-12-31 | $861.00K 10-Q · filed 2011-11-10 |
| 2008-02-25 | $2.28M 10-K · filed 2014-03-21 |
| 2008-02-04 | $984.00K 10-K · filed 2018-03-29 |
| 2003-05-31 | $261.00K 10-K · filed 2014-03-21 |
| 2002-12-31 | $236.00K 10-K · filed 2014-03-21 |
| 2001-12-31 | $886.00K 10-K · filed 2014-03-21 |
| 2001-08-31 | $503.00K 10-K · filed 2014-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |